Filing Details
- Accession Number:
- 0001567619-21-018407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-18 16:45:10
- Reporting Period:
- 2021-10-15
- Accepted Time:
- 2021-10-18 16:45:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1275187 | Angiodynamics Inc | ANGO | Surgical & Medical Instruments & Apparatus (3841) | 113146460 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1823973 | Scott Centea | 14 Plaza Drive Latham NY 12110 | Sr. Vp/Gm, Global Vit | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-15 | 12,000 | $16.77 | 58,244 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-10-15 | 12,000 | $27.92 | 46,244 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-10-15 | 12,000 | $0.00 | 12,000 | $16.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-10-24 | 2024-10-24 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.85 to $27.99, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
- Options for one-fourth of the shares became exercisable on 10/24/2015, 10/24/2016, 10/24/2017 and 10/24/2018, respectively.
Billionaire Hedge Funds
